Dr Reddy's gets nod for anti-platelet drug in China

26 Apr 2019 Evaluate

Dr. Reddy's Laboratories has received approval for anti-platelet drug Clopidogrel in China. The company believes that the sales from this product will not be material in the current financial year (FY20).

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5784.50 -92.20 (-1.57%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.